Back to Journals » Journal of Inflammation Research » Integrating Artificial Intelligence into Inflammation and Cancer Immunology: From Biomarkers Discovery and Mechanistic Insights to Precision Therapeutics
Journal of Inflammation Research
- View all (4115)
- Volume 19, 2026 (296)
- Volume 18, 2025 (1174)
- Volume 17, 2024 (804)
- Volume 16, 2023 (460)
- Volume 15, 2022 (493)
- Volume 14, 2021 (541)
- Volume 13, 2020 (112)
- Volume 12, 2019 (35)
- Volume 11, 2018 (47)
- Volume 10, 2017 (20)
- Volume 9, 2016 (24)
- Volume 8, 2015 (21)
- Volume 7, 2014 (17)
- Volume 6, 2013 (14)
- Volume 5, 2012 (17)
- Volume 4, 2011 (13)
- Volume 3, 2010 (15)
- Volume 2, 2009 (6)
- Volume 1, 2008 (6)
Journal Articles:
- Omics, Microbiome, and Artificial Intelligence: Novel Insights into Human Disease-Associated Inflammatory Responses (3)
- Targeting the IL-4/IL-13 Axis in the Treatment of Type 2 Inflammation (7)
- Inflammaging in Cardiovascular and Chronic Disease (4)
- Neutrophils in a New Light: Emerging Roles in Inflammation (3)
- Anti-inflammatory Biologics – A Game Changer for Chronic Inflammation (5)
- Cellular and Molecular Drivers of Lung Inflammation in Respiratory Diseases (1)
- The Translation of Discovery: Cutting Edge Research to Study Airway Inflammation (1)
- Takayasu Arteritis: Insights Into Pathogenesis, Disease Assessment, Treatment, and Outcomes (2)
- Inflammation and brain: how inflammatory processes influence physiological and pathological functions of the central nervous system (12)
- Genetic and non-genetic inflammation networks in major human diseases (6)
- Neurodegenerative diseases: From Pathogenesis to Treatment (1)
- Unraveling the Complex Relationship Between Inflammation, Diabetes, and Obesity: A Comprehensive Exploration (2)
Integrating Artificial Intelligence into Inflammation and Cancer Immunology: From Biomarkers Discovery and Mechanistic Insights to Precision Therapeutics
Inflammation exerts a complex and context-dependent influence on both oncogenesis and the efficacy of cancer therapies. Acute inflammatory responses may enhance anti-tumor immunity; however, chronic inflammation is more commonly implicated in tumor initiation, progression, and the facilitation of immune evasion. Persistent inflammatory signaling contributes to the development of an immunosuppressive tumor microenvironment (TME) by promoting the infiltration of immunoregulatory cell populations, including regulatory T cells, myeloid-derived suppressor cells, and M2-polarized macrophages. This Article Collection gathers interdisciplinary research that investigate the role and underlying mechanisms of epigenetic alterations in the regulation of inflammation and tumor immunity.